Skip to content

Form 4 filed by Taddese Menassie

Taddese Menassie filed this Form 4 on XERS (Xeris Biopharma Holdings, Inc.) with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-04 21:56:40 UTC.

Accession
0001867096-26-000105
Filed
2026-11-04
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: XERS · Xeris Biopharma Holdings, Inc. (CIK 1867096)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-02A granted+22,365$022,365D
Stock Option (Right to Buy) derivative2026-11-02A granted-31,499$10.1731,499D